To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Vaccine Development and Bioprocess Cell Culture Technology Day in Baltimore
Read time: Less than a minute
On May 16, 2019 the Vaccine Development and Bioprocess Cell Culture Technology Day will take place in Baltimore. Experts will discuss technologies in cell culture upstream bioprocess development with a special focus on perfusion technologies and scale-up.
The Vaccine Development and Bioprocess Cell Culture Technology Day is organized by the leading life science company Eppendorf AG. “Today, scalable bioprocess systems, online process analytics, and process intensification are key for the development of robust, cost-efficient bioprocesses,” comments Dr. Karl Rix, Vice President Business Unit Bioprocess at Eppendorf. “We are excited that bioprocess experts from Eppendorf, as well as representatives from Corning and other leading manufacturers will share their latest bioprocess insights.”
“Driven by epidemic events and governmental vaccination programs there is a rising demand for the development of new vaccines,” Rix states. “We are excited to learn about the latest developments in upstream bioprocessing that help balance costs and time-to-market.”
The Vaccine Development and Bioprocess Cell Culture Technology Day is organized by the leading life science company Eppendorf AG. “Today, scalable bioprocess systems, online process analytics, and process intensification are key for the development of robust, cost-efficient bioprocesses,” comments Dr. Karl Rix, Vice President Business Unit Bioprocess at Eppendorf. “We are excited that bioprocess experts from Eppendorf, as well as representatives from Corning and other leading manufacturers will share their latest bioprocess insights.”
“Driven by epidemic events and governmental vaccination programs there is a rising demand for the development of new vaccines,” Rix states. “We are excited to learn about the latest developments in upstream bioprocessing that help balance costs and time-to-market.”
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
